SACUBITRIL/VALSARTAN USE IN A REAL WORLD EXPERIENCE: DATA FROM A LARGE SINGLE-CENTER POPULATION OF HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION

被引：0
|
作者：
Mapelli, M.
Salvioni, E.
Mattavelli, I.
Sassi, V.
Gugliandolo, P.
Mantegazza, V.
Volpato, V.
Vignati, C.
De Martino, F.
Paolillo, S.
Contini, M.
Apostolo, A.
Magini, A.
Palermo, P.
Agostoni, P.
机构：
[1] IRCCS, Ctr Cardiol Monzino, Milan, Italy
[2] Univ Federico II, Naples, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2020年 / 22卷 / 0G期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P361
引用
收藏
页码：G188 / G189
页数：2
相关论文
共 50 条
  • [21] Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study
    Ganesananthan, Sashiananthan
    Shah, Nisar
    Shah, Parin
    Elsayed, Hossam
    Phillips, Julie
    Parkes, Ann
    Morgan, Angharad
    Yousef, Zaheer
    OPEN HEART, 2020, 7 (02):
  • [22] Temporal trend in diuretic use in patients with heart failure with reduced ejection fraction on sacubitril/valsartan
    Jain, D. Divyanshu
    Prendiville, T.
    Connolly, N.
    Travers, B.
    Halloran, A. O'
    Molloy, A.
    Al Maini, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 183 - 184
  • [23] Factors associated with the use of sacubitril valsartan in patients with heart failure and reduced ejection fraction.
    Jorge Thierer, J.
    Ritondale, N.
    Palacio, M. S.
    Lobo Marquez, L.
    Aguilar, E.
    Soricetti, J.
    Ratto, R.
    Fernandez, D.
    Sanz, G.
    Echazarreta, D.
    Mazo, G.
    Bauk, L.
    Martin Napoli, M.
    Pereiro Gonzalez, S. M.
    Marino, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 228 - 229
  • [24] Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Chiou, Wei-Ru
    Huang, Jin-Long
    Lin, Wen-Yu
    Liao, Chia-Te
    Chung, Fa-Po
    Liang, Huai-Wen
    Hsu, Chien-Yi
    Chang, Hung-Yu
    ESC HEART FAILURE, 2021, 8 (02): : 1204 - 1215
  • [25] Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation
    Chang, Hung-Yu
    Feng, An-Ning
    Fong, Man-Cai
    Hsueh, Chao-Wen
    Lai, Wei-Tsung
    Huang, Kuan-Chih
    Chong, Eric
    Chen, Chi-Nan
    Chang, Hung-Chuan
    Yin, Wei-Hsian
    JOURNAL OF CARDIOLOGY, 2019, 74 (3-4) : 372 - 380
  • [26] Sacubitril/valsartan in heart failure with reduced ejection fraction patients: real world experience on advanced chronic kidney disease, hypotension and dose titration
    Chang, H-Y Hung-Yu
    Hsieh, C-W
    Fong, M-C
    Feng, A-N
    Huang, K-C
    Lai, W-T
    Yin, W-H
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 416 - 416
  • [27] PHARMACOUTILIZATION AND ADHERENCE TO SACUBITRIL/VALSARTAN IN REAL-WORLD: THE REAL.IT STUDY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    Iacoviello, M.
    Di Gesaro, G.
    Sarullo, F.
    Miani, D.
    Driussi, M.
    Correale, M.
    Bilato, C.
    Passantino, A.
    Carluccio, E.
    Villani, A.
    Esposti, L. Degli
    D'Agostino, C.
    Peruzzi, E.
    Poli, S.
    Di Lenarda, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [28] Sacubitril/valsartan in chronic heart failure with reduced ejection fraction: a guide to its use
    Keating G.M.
    McCormack P.L.
    Drugs & Therapy Perspectives, 2017, 33 (1) : 1 - 7
  • [29] Real-World Analysis of Diuretic Requirements in Patients with Heart Failure with Reduced Ejection Fraction after Initiation of Sacubitril/Valsartan
    Miah, A.
    Ahmed, U.
    Pirlamarla, P.
    Reeves, G.
    Abbas, C.
    Shah, M.
    Alvarez, R.
    Cozzi, S.
    Demastus, C.
    Ervin, A.
    Danelich, I.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S152 - S153
  • [30] Sacubitril/Valsartan in the Treatment of Right Ventricular Dysfunction in Patients With Heart Failure With Reduced Ejection Fraction: A Real-world Study
    Yang, Ying
    Shen, Chao
    Lu, Jiangting
    Fu, Guosheng
    Xiong, Cui
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 177 - 182
12345